DIR Return Create A Forum - Home
---------------------------------------------------------
Camelot Fantasies
HTML https://castleknights.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: Stocks Universe
*****************************************************
#Post#: 62017--------------------------------------------------
ICCLF
By: Clay Death Date: April 27, 2017, 8:50 am
---------------------------------------------------------
ICC Enters Into Importation Agreement With ARA - Avanti Rx
Analytics
7:30 am ET April 18, 2017 (Market Wire) Print
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 18, 2017) -
ICC International Cannabis Corporation ("ICC" or the "Company")
(TSX VENTURE:ICC) is pleased to announce that it has entered
into an Importation Agreement with ARA - Avanti Rx Analytics
Inc. ("Avanti"), a licensed dealer under the Controlled Drugs
and Substances Act (Canada) and its regulations overseen by
Health Canada.
"We are pleased to enter into the Importation Agreement with
Avanti with a view to working together to provide Canadians with
a broader supply of cannabidiol ('CBD') oil and cannabis extract
oils, and other related products from our Uruguayan operations
at competitive price points," commented Guillermo Delmonte,
Chief Executive Officer of ICC. "In addition, Avanti brings to
the table extensive knowledge and expertise in the field of
quality control, cannabis extraction, and CBD purification. The
business relationship with Avanti is expected to allow ICC to
leverage Avanti's dealer license and laboratory facilities in
order to facilitate sales in Canada, and represents a positive
next step in ICC's strategy to export to global markets where
lawful."
The Importation Agreement establishes a non-exclusive
contractual business relationship between ICC and Avanti where
Avanti agrees to act as a Canadian importing agent for ICC for
its cannabis products and distributor to customers identified by
ICC from time to time. Avanti has also agreed to act as a Health
Canada GMP approved contract analytical lab in Canada for ICC's
CBD oil. The activities contemplated by the Importation
Agreement remain subject to applicable regulatory approvals,
including those from the TSX Venture Exchange, the Instituto de
Regulación y Control del Cannabis ("IRCCA"), the Uruguayan
Ministry of Livestock, Agriculture and Fishery and Health
Canada.
ABOUT ICC INTERNATIONAL CANNABIS CORPORATION
The Company has operations in Uruguay, and is focused on the
licensed production, development and sale of recreational
cannabis, cannabinoid extracts and by-products for medicinal
uses and industrial hemp. For more information, please see
www.intcannabiscorp.com.
ABOUT ARA - AVANTI RX ANALYTICS INC.
Avanti specializes in the field of controlled drugs and
substances particularly in the area of medicinal marihuana,
hemp, cannabinoids, and marihuana based concentrated products.
Avanti offers a comprehensive menu of services ranging from
analytical R&D and quality control testing, cannabis extraction
under controlled environment, cannabinoids purification,
cannabis infused-product formulation, packaging, and cannabis
waste management by means of material denaturation, as well as
the quality assurance and regulatory consulting.
Neither the TSX Venture Exchange ("TSXV") nor its Regulation
Services Provider (as that term is defined in the policies of
the TSXV) accepts responsibility for the adequacy or accuracy of
this release.
Certain information in this press release may constitute
forward-looking information. This information is based on
current expectations that are subject to significant risks and
uncertainties that are difficult to predict, including: (i) the
Company's ability to obtain the requisite regulatory approvals
in Canada and Uruguay, including approvals from the TSX Venture
Exchange, Health Canada, the Uruguayan Ministry of Livestock,
Agriculture and Fishery and IRCCA; (ii) the Company's ability to
produce the requisite cannabis products for export; (iii) the
agricultural risks associated with cannabis production in
Uruguay; and (iv) the ability to sell its cannabis products at
competitive price points. Actual results might differ materially
from results suggested in any forward-looking statements. The
Company assumes no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those reflected in the forward looking-statements
unless and until required by securities laws applicable to the
Company.
Additional information identifying risks and uncertainties is
contained in the Company's filings with the Canadian securities
regulators, which filings are available at www.sedar.com.
ICC International Cannabis Corporation Guillermo Delmonte Chief
Executive Officer and Director 598-2900-0000
ir@intcannabiscorp.com www.intcannabiscorp.com
*****************************************************